干细胞特异性长链非编码RNA HOXA10-AS在KMT2A重排白血病发病机制中的作用
HOX基因表达失调可致白血病,但HOX簇内长链非编码RNA的作用尚不清楚。本研究表明lncRNA HOXA10-AS在造血干细胞及KMT2A重排、NPM1突变AML中高表达,通过反式激活NF-κB靶基因发挥致癌作用,其敲低可损害白血病生长,高表达提示预后不良。
要点
- HOXA10-AS在HSC及KMT2A重排、NPM1突变AML中高表达
- HOXA10-AS敲低或CRISPR切除可抑制KMT2A重排AML生长
- HOXA10-AS高表达可作为AML预后不良标志
核心结论
- HOXA10-AS是KMT2A重排AML中的致癌lncRNA,可能成为潜在治疗靶点。
研究设计与样本
- 体外采用shRNA、LNA-GapmeR敲低及CRISPR/Cas9切除研究HOXA10-AS功能。
- 体内使用KMT2A重排患者来源异种移植模型评估敲低效果。
主要发现
- HOXA10-AS在HSC及KMT2A重排、NPM1突变AML中高表达。
- HOXA10-AS敲低严重损害KMT2A重排PDX的白血病生长。
- HOXA10-AS高表达可作为AML患者预后不良的标志。
- 慢病毒表达HOXA10-AS阻断人CD34+造血干祖细胞的正常单核分化。
- HOXA10-AS定位于细胞质,通过反式作用诱导NF-κB靶基因。
临床怎么用
- HOXA10-AS高表达可用于AML患者预后分层。
- 靶向HOXA10-AS可能为KMT2A重排AML提供治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HOX genes are highly conserved, and their precisely controlled expression is crucial for normal hematopoiesis. Accordingly, deregulation of HOX genes can cause leukemia. However, despite of intensive research on the coding HOX genes, the role of the numerous long noncoding RNAs (lncRNAs) within the HOX clusters during hematopoiesis and their contribution to leukemogenesis are incompletely understood. Here, we show that the lncRNA HOXA10-AS, located antisense to HOXA10 and mir-196b in the HOXA cluster, is highly expressed in hematopoietic stem cells (HSCs) as well as in KMT2A-rearranged and NPM1 mutated acute myeloid leukemias (AMLs). Using short hairpin RNA- and locked nucleic acid-conjugated chimeric antisense oligonucleotide (LNA-GapmeR)-mediated HOXA10-AS-knockdown and CRISPR/Cas9-mediated excision in vitro, we demonstrate that HOXA10-AS acts as an oncogene in KMT2A-rearranged AML. Moreover, HOXA10-AS knockdown severely impairs the leukemic growth of KMT2A-rearranged patient-derived xenografts in vivo, while high HOXA10-AS expression can serve as a marker of poor prognosis in AML patients. Lentiviral expression of HOXA10-AS blocks normal monocytic differentiation of human CD34+ hematopoietic stem and progenitor cells. Mechanistically, we show that HOXA10-AS localizes in the cytoplasm and acts in trans to induce NF-κB target genes. In total, our data imply that the normally HSC-specific HOXA10-AS is an oncogenic lncRNA in KMT2A-r AML. Thus, it may also represent a potential therapeutic target in KMT2A-rearranged AML.
引用
- Al-Kershi S, Bhayadia R, Ng M, et al. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia. Blood Adv. 2019. PMID: 31867596. doi:10.1182/bloodadvances.2019032029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。